1.42
전일 마감가:
$1.53
열려 있는:
$1.49
하루 거래량:
938.98K
Relative Volume:
1.68
시가총액:
$54.87M
수익:
$40.93M
순이익/손실:
$-15.57M
주가수익비율:
-3.8141
EPS:
-0.3723
순현금흐름:
$-17.84M
1주 성능:
-7.79%
1개월 성능:
+56.03%
6개월 성능:
+54.35%
1년 성능:
-48.36%
Myomo Inc Stock (MYO) Company Profile
명칭
Myomo Inc
전화
617-996-9058
주소
One Broadway, 14th Floor, Cambridge, MA
Compare MYO vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
MYO
Myomo Inc
|
1.42 | 52.16M | 40.93M | -15.57M | -17.84M | -0.3723 |
|
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-31 | 개시 | Craig Hallum | Buy |
| 2024-05-20 | 개시 | Lake Street | Buy |
| 2023-12-15 | 개시 | H.C. Wainwright | Buy |
| 2020-11-11 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2020-05-27 | 개시 | Dougherty & Company | Buy |
| 2017-10-02 | 개시 | H.C. Wainwright | Buy |
모두보기
Myomo Inc 주식(MYO)의 최신 뉴스
MYOMO INC (MYO) Stock Chart - ChartMill
Myomo (NYSE: MYO) CMO sells shares to cover income tax bill - Stock Titan
Myomo (MYO) CCO uses 9,061 shares to cover RSU tax obligations - Stock Titan
Myomo (MYO) CFO has 10,969 shares withheld to cover RSU tax bill - Stock Titan
Myomo (MYO) RSUs Vest 20,979; Director reported sales on multiple dates - Stock Titan
Myomo (MYO) RSUs vest 19,813 shares; insider sales reported - Stock Titan
Myomo director Thomas F Kirk buys $50,802 in common stock By Investing.com - Investing.com Australia
Myomo director Thomas F Kirk buys $50,802 in common stock - Investing.com
Insider Buying: Thomas Kirk Acquires 40,002 Shares of Myomo Inc (MYO) - GuruFocus
MYOMO (MYO) CCO uses 6,529 shares to cover RSU tax liability - Stock Titan
MYOMO (MYO) Chief Medical Officer disposes shares to cover RSU tax - Stock Titan
Myomo (NYSE: MYO) CFO uses 10,050 vested shares to cover tax bill - Stock Titan
Director F. Kirk Thomas adds 40,002 Myomo (NYSE: MYO) shares in open-market buy - Stock Titan
MYO Maintained by Ascendiant Capital -- Price Target Raised to $10.00 - GuruFocus
Myomo CCO Mitchell Micah sells $77,688 in stock By Investing.com - Investing.com Australia
Myomo CCO Mitchell Micah sells $77,688 in stock - Investing.com
Myomo (NYSE American: MYO) lists 17,666 RSUs vesting; brokered sales reported - Stock Titan
Myomo (MYO) Chief Commercial Officer sells 90,231 shares in May 2026 - Stock Titan
Myomo (MYO) Form 144: Insider notice for 16,666 RSU shares vesting - Stock Titan
Number of shareholders of Myomo Inc. – AMEX:MYO - TradingView
Myomo director Thomas Kirk buys $24,825 in company stock By Investing.com - Investing.com South Africa
Myomo director Thomas Kirk buys $24,825 in company stock - Investing.com India
Myomo (MYO) director buys 25K open-market shares of Common Stock - Stock Titan
Myomo (MYO) shows fast-paced momentum but is still a bargain stock - MSN
Myomo CMO Kovelman sells $32,239 in company stock By Investing.com - Investing.com UK
Insider Sell Alert: Harry Kovelman Sells 32,000 Shares of Myomo Inc (MYO) - GuruFocus
Myomo CMO Kovelman sells $32,239 in company stock - Investing.com
MYOMO (MYO) Chief Medical Officer sells 32,000 shares in open-market trades - Stock Titan
Rule 144 Notice: MYO (NYSE) — 11,536 Common Shares Listed for Sale - Stock Titan
Myomo (MYO) Shows Fast-paced Momentum But Is Still a Bargain Stock - Yahoo Finance
MYO (NYSE) affiliate lists multiple restricted stock sales on Form 144 - Stock Titan
Myomo, Inc. (MYO) reports Q1 loss, beats revenue estimates - MSN
MYO: Wearable robotics drive growth with expanding reimbursement and recurring revenue focus - TradingView
MYO: Recurring revenue and expanded payer coverage fuel growth and improved financial outlook - TradingView
MYO: Recurring revenue and expanded coverage drive growth, with 2026 revenue guided at $43–$46 million - TradingView
Myomo reiterates $40M–$42M 2025 revenue target as O&P channel, MyoConnect drive growth - MSN
Myomo director Kirk Thomas F buys $68,242 in company stock By Investing.com - Investing.com Nigeria
Myomo (MYO) director adds 75,006 shares through open‑market buying - Stock Titan
Myomo director Kirk Thomas F buys $68,242 in company stock - Investing.com
Myomo | 4: Statement of changes in beneficial ownership of securities-Director KIRK THOMAS F - Moomoo
Myomo director Manko Jr. acquires $173,907 in MYO stock By Investing.com - Investing.com South Africa
Horton Capital (MYO) reports 6% Myomo stake, wins board role and pushes declassification - Stock Titan
Myomo director Manko Jr. acquires $173,907 in MYO stock - Investing.com
Director-linked Horton Capital fund boosts Myomo (NYSE: MYO) stake with open-market buys - Stock Titan
Myomo Inc (MYO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):